Lfa (Lateral Flow Assay) Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Lfa (Lateral Flow Assay) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.6% during the forecast period.

    This report presents the market size and development trends by detailing the Lfa (Lateral Flow Assay) market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Lfa (Lateral Flow Assay) market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Lfa (Lateral Flow Assay) industry and will help you to build a panoramic view of the industrial development.

    Lfa (Lateral Flow Assay) Market, By Type:

    • Type 1

    • Type 2

    • Type 3

    Lfa (Lateral Flow Assay) Market, By Application:

    • Pregnancy

    • Drugs

    • Swine flue

    • HIV

    • Others

    Some of the leading players are as follows:

    • Scienion

    • Sartorius

    • Senova

    • Kestrel Bio

    • Pall

    • Cytodiagnostics

    • BBI Solutions

    • GE healthcare

    • ANP Technology, Inc

    • Qiagen

    • BioDot, Inc

    • DCN

    • Merck Millipore

    • IMMY

    • Skannex

    • Abingdon Health

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Lfa (Lateral Flow Assay) Market: Technology Type Analysis

    • 4.1 Lfa (Lateral Flow Assay) Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Lfa (Lateral Flow Assay) Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Type 1

      • 4.3.2 Type 2

      • 4.3.3 Type 3

    5 Lfa (Lateral Flow Assay) Market: Product Analysis

    • 5.1 Lfa (Lateral Flow Assay) Product Market Share Analysis, 2018 & 2026

    • 5.2 Lfa (Lateral Flow Assay) Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Lfa (Lateral Flow Assay) Market: Application Analysis

    • 6.1 Lfa (Lateral Flow Assay) Application Market Share Analysis, 2018 & 2026

    • 6.2 Lfa (Lateral Flow Assay) Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Pregnancy

      • 6.3.2 Drugs

      • 6.3.3 Swine flue

      • 6.3.4 HIV

      • 6.3.5 Others

    7 Lfa (Lateral Flow Assay) Market: Regional Analysis

    • 7.1 Lfa (Lateral Flow Assay) Regional Market Share Analysis, 2018 & 2026

    • 7.2 Lfa (Lateral Flow Assay) Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Scienion

      • 9.1.1 Scienion Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Sartorius

      • 9.2.1 Sartorius Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Senova

      • 9.3.1 Senova Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Kestrel Bio

      • 9.4.1 Kestrel Bio Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Pall

      • 9.5.1 Pall Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Cytodiagnostics

      • 9.6.1 Cytodiagnostics Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 BBI Solutions

      • 9.7.1 BBI Solutions Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 GE healthcare

      • 9.8.1 GE healthcare Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 ANP Technology, Inc

      • 9.9.1 ANP Technology, Inc Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Qiagen

      • 9.10.1 Qiagen Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 BioDot, Inc

      • 9.11.1 BioDot, Inc Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 DCN

      • 9.12.1 DCN Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 Merck Millipore

      • 9.13.1 Merck Millipore Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 IMMY

      • 9.14.1 IMMY Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 Skannex

      • 9.15.1 Skannex Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 Abingdon Health

      • 9.16.1 Abingdon Health Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

     

    The List of Tables and Figures (Totals 84 Figures and 155 Tables)

    • Figure Type 1 Lfa (Lateral Flow Assay) market, 2015 - 2026 (USD Million)

    • Figure Type 2 Lfa (Lateral Flow Assay) market, 2015 - 2026 (USD Million)

    • Figure Type 3 Lfa (Lateral Flow Assay) market, 2015 - 2026 (USD Million)

    • Figure Pregnancy market, 2015 - 2026 (USD Million)

    • Figure Drugs market, 2015 - 2026 (USD Million)

    • Figure Swine flue market, 2015 - 2026 (USD Million)

    • Figure HIV market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Lfa (Lateral Flow Assay) market, by country, 2015 - 2026 (USD Million)

    • Table North America Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table North America Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table North America Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table Canada Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table Canada Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Europe Lfa (Lateral Flow Assay) market, by country, 2015 - 2026 (USD Million)

    • Table Europe Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table Europe Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table Europe Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table Germany Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table Germany Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table France Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table France Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table Italy Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table Italy Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table Spain Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table Spain Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Lfa (Lateral Flow Assay) market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table China Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table China Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table Japan Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table Japan Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table India Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table India Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Lfa (Lateral Flow Assay) market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table MEA Lfa (Lateral Flow Assay) market, by country, 2015 - 2026 (USD Million)

    • Table MEA Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table MEA Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table MEA Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Lfa (Lateral Flow Assay) market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Lfa (Lateral Flow Assay) market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Lfa (Lateral Flow Assay) market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Scienion Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sartorius Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Senova Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Kestrel Bio Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pall Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cytodiagnostics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BBI Solutions Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GE healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table ANP Technology, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Qiagen Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BioDot, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table DCN Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Merck Millipore Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table IMMY Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Skannex Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Abingdon Health Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.